Literature DB >> 1588050

Usage of primary cells to delineate IFN-gamma-responsive DNA elements in the HLA-DRA promoter and to identify a novel IFN-gamma-enhanced nuclear factor.

H Moses1, R B Panek, E N Benveniste, J P Ting.   

Abstract

The IFN-gamma regulation of the HLA-DRA gene was examined in a primary cell type, the astrocyte. Site-specific mutagenesis of the DRA promoter reveals that three known sequences, S, X, and Y, are required for an optimal IFN-gamma response. Specifically for the X sequence, the X1, but not the X2, site is involved in IFN-gamma regulation of HLA-DRA in the astrocyte. Most interesting, a novel IFN-gamma-enhanced protein (IFNEX) with specificity for the X element has consistently been observed in nuclear extracts made from primary astrocytes. The correlation of the functional importance of X1 in IFN-gamma-regulated DRA expression and the enhancement of IFNEX by IFN-gamma strongly suggests that IFNEX may play a crucial role in IFN-gamma-regulated class II MHC gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588050

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Current concepts in DRA gene regulation.

Authors:  J P Ting
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

2.  Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter.

Authors:  X S Zhu; M W Linhoff; G Li; K C Chin; S N Maity; J P Ting
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

3.  The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds.

Authors:  Y Kanno; C A Kozak; C Schindler; P H Driggers; D L Ennist; S L Gleason; J E Darnell; K Ozato
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

4.  Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.

Authors:  R B Panek; H Moses; J P Ting; E N Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

5.  In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.

Authors:  K L Wright; J P Ting
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  Affinity enrichment and functional characterization of TRAX1, a novel transcription activator and X1-sequence-binding protein of HLA-DRA.

Authors:  Y Itoh-Lindstrom; B M Peterlin; J P Ting
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

7.  Activation of the HLA-DRA gene in primary human T lymphocytes: novel usage of TATA and the X and Y promoter elements.

Authors:  G K Matsushima; Y Itoh-Lindstrom; J P Ting
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

8.  Identification of a transcription factor that binds to the S box of the I-A beta gene of the major histocompatibility complex.

Authors:  A Celada; P Gil; S R McKercher; R A Maki
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

9.  CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors.

Authors:  K L Wright; B J Vilen; Y Itoh-Lindstrom; T L Moore; G Li; M Criscitiello; P Cogswell; J B Clarke; J P Ting
Journal:  EMBO J       Date:  1994-09-01       Impact factor: 11.598

10.  Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter.

Authors:  K L Wright; L C White; A Kelly; S Beck; J Trowsdale; J P Ting
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.